Clinical Trial Update: Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies [Phase 3]

View source ↗

Summary

A Phase 3 post-marketing study evaluating KamRAB given as a single dose with active rabies vaccine in children exposed to rabies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• KamRAB

Snippet

Sponsor: Kamada, Ltd. | Conditions: Rabies | Phase 3 | Status: COMPLETED